EFFICACY OF SUPRASPINATUS NERVE APPROACH THROUGH CORTICOSTEROID ADMINISTRATION VERSUS PULSED RADIOFREQUENCY IN CHRONIC SHOULDER PAIN. DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL.
EU CTIS ID: 2024-519892-24-00
What this study is testing
Evaluation of Improvement in Shoulder Functionality and Pain Measured by the SPADI Test in Patients with Chronic Shoulder Pain: Comparison of Suprascapular Nerve Block with Corticosteroids versus Pulsed Radiofrequency.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Men and women scheduled for suprascapular nerve block due to shoulder pain (omalgia).
- Age >18 years.
- Shoulder pain (omalgia) lasting >3 months.
- Signed informed consent form.
You likely can't join if
- Allergy to corticosteroids.
- Systemic infections.
- Women of childbearing potential not using highly effective contraceptive methods (as defined in the ICH M3 guidance, Note 3).
- Patient refusal.
- Blood dyscrasias.
- Inability to perform the infiltration due to technical difficulties.
See the full eligibility criteria
- Men and women scheduled for suprascapular nerve block due to shoulder pain (omalgia).
- Age >18 years.
- Shoulder pain (omalgia) lasting >3 months.
- Signed informed consent form.
- Allergy to corticosteroids.
- Systemic infections.
- Women of childbearing potential not using highly effective contraceptive methods (as defined in the ICH M3 guidance, Note 3).
- Patient refusal.
- Blood dyscrasias.
- Inability to perform the infiltration due to technical difficulties.
- Lack of understanding of the informed consent document.
- Pregnancy or breastfeeding.
- External causes of shoulder pain (omalgia), such as secondary to stroke, post-surgical conditions (shoulder surgery, laparoscopic surgery, or thoracic surgery), or cervicobrachial syndrome.
- Severe pain in other locations, specifically in cases of polymyalgic syndromes (fibromyalgia), other conditions with poor response to treatments (chronic fatigue syndrome), or at the physician's discretion.
- Participation in other studies that may affect the results.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.